- Home
- FTRE vs TLRY Comparison
FTRE vs TLRY Comparison
Compare FTRE & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- TLRY
- Stock Information
- Founded
- FTRE 1996
- TLRY N/A
- Country
- FTRE United States
- TLRY Canada
- Employees
- FTRE N/A
- TLRY N/A
- Industry
- FTRE Medical Specialities
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- FTRE Health Care
- TLRY Health Care
- Exchange
- FTRE Nasdaq
- TLRY Nasdaq
- Market Cap
- FTRE 701.9M
- TLRY 624.7M
- IPO Year
- FTRE N/A
- TLRY 2018
- Fundamental
- Price
- FTRE $8.86
- TLRY $1.39
- Analyst Decision
- FTRE Hold
- TLRY Buy
- Analyst Count
- FTRE 10
- TLRY 4
- Target Price
- FTRE $14.00
- TLRY $1.58
- AVG Volume (30 Days)
- FTRE 1.7M
- TLRY 82.2M
- Earning Date
- FTRE 08-06-2025
- TLRY 10-09-2025
- Dividend Yield
- FTRE N/A
- TLRY N/A
- EPS Growth
- FTRE N/A
- TLRY N/A
- EPS
- FTRE N/A
- TLRY N/A
- Revenue
- FTRE $2,733,500,000.00
- TLRY $821,309,000.00
- Revenue This Year
- FTRE N/A
- TLRY $7.44
- Revenue Next Year
- FTRE N/A
- TLRY $4.66
- P/E Ratio
- FTRE N/A
- TLRY N/A
- Revenue Growth
- FTRE N/A
- TLRY 4.10
- 52 Week Low
- FTRE $3.97
- TLRY $0.35
- 52 Week High
- FTRE $25.28
- TLRY $1.94
- Technical
- Relative Strength Index (RSI)
- FTRE 71.99
- TLRY 73.82
- Support Level
- FTRE $7.40
- TLRY $1.01
- Resistance Level
- FTRE $8.36
- TLRY $1.37
- Average True Range (ATR)
- FTRE 0.68
- TLRY 0.15
- MACD
- FTRE 0.10
- TLRY 0.03
- Stochastic Oscillator
- FTRE 97.75
- TLRY 97.50
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. USA exposure consists of CBD products and alcohol.